LAMR 241220 134.75P (LAMR241220P134750) Stock Options, News & Quotes

US OptionsDetailed Quotes

LAMR241220P134750

Watchlist

11.25
+7.95+240.91%

15min DelayClose Dec 19 16:00 ET

11.25High11.25Low

Intraday

5D
Daily

News

Morgan Stanley Maintains Lamar Advertising Co(LAMR.US) With Hold Rating, Maintains Target Price $135
Moomoo NewsDec 18 11:32 ET · Ratings
Lamar Advertising Co To Go Ex-Dividend On December 18th, 2024 With 1.4 USD Dividend Per Share And 0.25 USD Special Dividend Per Share
Moomoo NewsDec 9 19:45 ET
TD Cowen Maintains Lamar Advertising Co(LAMR.US) With Buy Rating, Maintains Target Price $160
Moomoo NewsDec 9 06:31 ET · Ratings
Press Release: Lamar Advertising Company Announces Cash Dividends on Common Stock
Dow JonesDec 6 16:15 ET
Express News | Lamar Advertising Company Announces Cash Dividends on Common Stock
ReutersDec 6 16:15 ET
Wall Street's Most Accurate Analysts Give Their Take On 3 Real Estate Stocks Delivering High-Dividend Yields
BenzingaNov 27 07:35 ET

Comments

Analysts Notebook

Jul 7, 2022 07:17

Columns Top upgrades and downgrades on 7/7: KSS, BG, GTLB, PATH and more

Upgrades
• $Allegiance (ABTX.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $43
• $Bunge (BG.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $106 (from $130)
• $Cerence (CRNC.US)$ : RBC Capital Upgrades to Sector Perform from Underperform - PT $27 (from $28)
• $First Mid Bancshares (FMBH.US)$ : Raymond James Upgrades to Outperform from Market Perform - PT $45
• $Lamar Advertising Co (LAMR.US)$ : Citigroup Up...

Moomoo Breakfast US

Jun 10, 2022 07:20

Columns Today's pre-market stock movers: DOCU, BGNE, RBLX, SFIX and more

Gainers:
• $Cogent Biosciences (COGT.US)$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions (UNVR.US)$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts (MTN.US)$ +6% (In reaction to earnings/guidance)
• $BeiGene (BGNE.US)$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...

Analysts Notebook

Jun 10, 2022 06:57

Columns Top upgrades and downgrades on 6/10: NFLX, EBAY, RBLX, EA and more

Upgrades
• $CME Group (CME.US)$ : Atlantic Equities Upgrades to Overweight from Neutral - PT $235
• $Spirit Airlines (SAVE.US)$ : JPMorgan Upgrades to Overweight from Neutral - PT $30 (from $24)
• $SciPlay (SCPL.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $17 (from $14.50)
Downgrades
• $Bilibili (BILI.US)$ : ICBC Downgrades to Neutral from Outperform - PT $26.20
• $Blueprint Medicines (BPMC.US)$ : Citigroup Downgrades to Se...